Renji Hospital

Urologic cancers: kidney preservation and precise prostate surgery

Renji’s robotic urology work includes kidney, prostate and bladder tumors. Kidney surgery seeks to remove the tumor while retaining functioning tissue. Prostate procedures consider nerves, the urethra and supporting structures alongside cancer control.

Jiahua Pan’s 2024 official profile records more than 2,000 robotic operations as primary surgeon and describes Retzius-sparing, transperineal and Hood approaches to prostate surgery. This provides a concrete basis for discussing how function preservation fits the proposed operation.

Liver tumours and complex liver disease

Liver surgery covers adult and paediatric liver disease and liver tumours. Liver function, tumour extent and previous therapy all shape the plan. Questions about organ transplantation need a separate review of medical indications and access eligibility; a hospital’s transplant programme does not establish an individual patient’s eligibility.

Digestive medicine and perioperative support

Digestive services and the broader hospital support assessment of hepatobiliary disease, nutrition and coexisting conditions. Patients considering complex surgery should flag chronic illnesses, blood thinners and previous anaesthetic problems early so the necessary reviews can be planned.

Gastroenterology and early digestive cancer assessment

Gastroenterology is a defining Renji strength. Academician Jingyuan Fang’s team studies gastric and colorectal carcinogenesis, early recognition and risk prediction, linking clinical gastroenterology with translational research. This expertise is relevant to precancerous disease and digestive cancer risk assessment.

Once cancer is diagnosed, pathology, invasion depth and stage inform referral for endoscopy, surgery or systemic treatment.

Gynecologic oncology and ovarian cancer research

Renji’s gynecologic cancer work is supported by obstetrics and gynecology and the Shanghai Key Laboratory of Gynecologic Oncology. The department combines clinical care and translational research in gynecologic malignancies, including ovarian cancer.

Women with significant autoimmune disease or other comorbidities may also need coordinated medical assessment. These conditions should be identified when the referral is prepared.

Breast cancer: diagnosis and systemic treatment

Jinsong Lu’s team works on early diagnosis and systemic treatment through a multidisciplinary breast program. Receptor and HER2 findings, pathology and stage inform the overall pathway, including the role and timing of surgery.

Planning may also address breast appearance and quality of life. Previously treated disease requires review of recurrence sites, tumor biology and earlier medication.

Rheumatology and complex autoimmune disease

Renji also has substantial rheumatology expertise. Shuang Ye and colleagues treat complex autoimmune conditions, including lupus, inflammatory muscle disease and associated interstitial lung disease.

Patients with both cancer and autoimmune disease may need joint assessment of disease activity, organ function and immunomodulating medication during treatment planning.

Biliary and pancreatic tumors

Yingbin Liu and colleagues work on gallbladder cancer, intrahepatic and hilar cholangiocarcinoma and pancreatic cancer, combining surgical resection with multidisciplinary treatment and translational research.

Planning considers vascular and biliary anatomy as well as jaundice, infection and nutrition. Contrast imaging and previous biliary procedure records help determine a feasible sequence of care.

Qiang Xia and the pediatric liver transplant team

Hepatoblastoma that cannot be removed by conventional resection

Xia’s team has a distinctive focus on pediatric liver transplantation. Its 2025 retrospective hepatoblastoma transplant cohort reported 5-year overall survival of 84.6%. This experience is relevant when conventional resection remains impossible after chemotherapy, provided extrahepatic disease and transplant eligibility are carefully assessed. The figure describes a selected single-center cohort and does not predict every child’s outcome.

Yingbin Liu

Surgical extent and molecular profiling in gallbladder cancer

Liu led a multicenter study of 121 patients with T1b gallbladder cancer from 24 hospitals, examining lymph-node dissection and additional liver resection. He also coauthored a 57-patient genomic study. These contributions are relevant when gallbladder cancer is unexpectedly found after surgery or further treatment must be assessed: bringing stage, surgical extent and molecular findings into the same decision.

Costs & payment

Ask what the hospital estimate includes, deposits, additional charges and refund arrangements. Plan travel and living costs separately. Insurance coverage and direct billing require confirmation.

Language & records

Confirm interpreting for appointments, communication during treatment and the language of records. Our China coordination includes Chinese and English support; other languages need advance confirmation of availability and arrangements.

Campus, accommodation & caregivers

Consultations, tests and admission may take place at different sites. Distance, accessibility, caregiver rules and follow-up frequency all affect the itinerary and should be considered once the clinical plan is clearer.

Length of stay & returning home

Assessment, surgery, radiotherapy and cellular treatment have different schedules. Ask the hospital for the expected course, allowing for results and changes in the plan. Confirm readiness to return home with the clinical team.

Make your history easier to review

Organise treatments and key reports, help with necessary translation and bring the important questions to the clinician.

Find the appropriate clinical service

Enquire with the relevant specialty, follow up on record requirements and help clarify acceptance and appointments.

Coordinate the practical steps in China

Within the agreed scope, help with visa documentation, travel, arrival transport, accommodation and accompaniment.

Keep communication connected

Help organise consultation feedback, records for home and follow-up requirements, with continued contact as agreed.

Is robotic surgery necessarily the right approach?

Robotics is a surgical tool. The choice still depends on tumour location and extent, prior operations and clinical judgement. Ask the surgeon to compare feasible approaches, recovery and functional effects, including whether medicines are needed before or after surgery.

Can I request one of the specialists featured here?

Tell us your preference and we can help enquire. The hospital confirms acceptance, the specialist’s involvement and who provides outpatient or inpatient care. It may also recommend another suitable clinician within the specialty.

Can I contact Chirona before choosing a hospital?

Yes. Share the diagnosis, treatment history and the decision you need help with. We can organise the questions to consider when comparing hospitals and explain the coordination available.

Does submitting records confirm treatment?

Submitting records starts the assessment. The hospital must confirm acceptance and clinical suitability and may require more information or in-person tests. Appointment confirmation, the treatment plan and costs should be clarified separately.